Management of Excessive Female Ejaculate Related to Skene's Gland Dysfunction
The management of excessive female ejaculate due to Skene's gland dysfunction should focus on pelvic physical therapy as the first-line treatment, followed by consideration of pharmacological approaches if necessary. 1
Understanding Female Ejaculation and Skene's Gland Function
- Female ejaculation originates from the paraurethral (Skene's) glands, which are homologous to the male prostate 2
- True female ejaculation involves the secretion of a few milliliters of thick, milky fluid containing prostate-specific antigen (PSA) during orgasm 3
- This should be distinguished from "squirting," which is the expulsion of larger volumes of diluted urine, and from coital incontinence 3
- Skene's glands may serve a protective function by secreting antimicrobial compounds that help prevent urinary tract infections 4
Diagnostic Approach
- Evaluate for excessive ejaculation by assessing:
- Rule out other causes of genital fluid release:
Treatment Algorithm
First-Line Approach
- Pelvic Physical Therapy
Second-Line Approaches
Pharmacological Management (if physical therapy is insufficient)
Hormonal Assessment
Adjunctive Measures
Lifestyle Modifications
Psychological Support
Important Considerations and Caveats
- Limited Evidence Base: There is a notable lack of high-quality studies specifically addressing excessive female ejaculation 2
- Avoid Surgical Approaches: Surgical management of ejaculatory disorders should be considered experimental and only used in clinical trials 1
- Differential Diagnosis: Ensure proper differentiation between true ejaculation, squirting, and coital incontinence, as management differs 3
- Partner Involvement: When possible, include partners in education and management planning 1
- Regular Reassessment: Monitor response to interventions and adjust treatment plan as needed 1
Special Situations
- If excessive ejaculation is causing significant distress or affecting quality of life, a combined approach using both physical therapy and pharmacological management may be more effective than either alone 1
- For patients with concurrent sexual dysfunction issues (such as orgasmic disorders), additional targeted therapies may be necessary 5